Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies999
Alzamend Neuro
Alzamend Neuro is an innovative biotech company that develops and commercializes drugs, treatments, and cures for Alzheimer's disease.
Sector
Subsector
Location
total rounds
total raised
Ryne Biotechnology
Ryne Biotechnology develops therapies for neurodegenerative movement disorders.
Sector
Subsector
Keywords
Location
total rounds
total raised
Aldagen
ALDAGEN is a biopharmaceutical company developing regenerative cell therapies to treat various medical conditions.
Sector
Subsector
Keywords
Location
total rounds
total raised
Biophytis
Biophytis is a clinical-stage biotechnology company that develops therapies to slow the degenerative processes associated with aging.
Sector
Subsector
Location
total rounds
total raised
M&A Details1
Transaction name
Acquired by
Sangamo Therapeutics
announced date
Financials
Funding Rounds3
Number of Funding Rounds
Money Raised
Their latest funding was raised on 11.11.2010. Their latest investor California Technology Ventures. Their latest round Series D
Michael J. Fox Foundation
Michael J. Fox Foundation is a non-profit research firm dedicated to finding better treatments and a cure for Parkinson's disease.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Investor Growth Capital Limited
Investor Growth Capital Limited is a venture capital firm based in Stockholm.
Sector
Subsector
Location
count Of Investments
count Of Exists
California Technology Ventures
California Technology Ventures, LLC (CTV) is a venture capital fund that invests in technology and life science companies.
Sector
Subsector
Location
count Of Investments
count Of Exists
Alta Partners
Alta Partners is a venture capital firm investing in healthcare and life sciences.
Sector
Subsector
Location
count Of Investments
count Of Exists
Co-Investors
Investors8
Number of lead investors
Number of investors
California Technology Ventures
California Technology Ventures, LLC (CTV) is a venture capital fund that invests in technology and life science companies.
Sector
Subsector
Location
count Of Investments
count Of Exists
Alta Partners
Alta Partners is a venture capital firm investing in healthcare and life sciences.
Sector
Subsector
Location
count Of Investments
count Of Exists
Investor Growth Capital Limited
Investor Growth Capital Limited is a venture capital firm based in Stockholm.
Sector
Subsector
Location
count Of Investments
count Of Exists
People
Founders1
Stephen Sherwin
Stephen Sherwin currently divides his time between advisory work in the life science industry and patient care and teaching in his specialty of medical oncology. He is a clinical professor of medicine at the University of California, San Francisco and a volunteer attending physician in hematology-oncology at the Zuckerberg San Francisco General Hospital. In his advisory work, Stephen serves as a director of Aduro Biotech, Biogen and Neurocrine Biosciences and as a venture partner at Third Rock Ventures. He is also a member of the scientific steering committee of the Parker Institute for Cancer Immunotherapy. Previously, Stephen was chairman and chief executive officer of Cell Genesys, a cancer immunotherapy company, from 1990 until the company’s merger in 2009 with BioSante Pharmaceuticals (now ANI Pharmaceuticals). He was also co-founder and chairman of Abgenix, an antibody company which was acquired by Amgen in 2006, and co-founder and chairman of Ceregene, a gene therapy company which was acquired by Sangamo Biosciences in 2013. From 1983 to 1990, he held various positions in clinical research at Genentech, most recently that of vice president, and prior to 1983, he was on the staff of the National Cancer Institute. In addition, Stephen previously served on the board of directors of the Biotechnology Industry Organization from 2001 to 2014 and as its chairman from 2009 to 2011, and was a member of the President’s Council of Advisors in Science and Technology (PCAST) Working Group on Drug Development from 2011 to 2013. Stephen holds a B.A. in biology from Yale University, an M.D. from Harvard Medical School and is board-certified in internal medicine and medical oncology and a fellow of the American College of Physicians.
current job
organization founded
Stephen Sherwin